Skip to main content
MEDICOX Co., Ltd. logo

MEDICOX Co., Ltd. — Investor Relations & Filings

Ticker · 054180 ISIN · KR7054180005 KO Manufacturing
Open in API
Filings indexed 803 across all filing types
Latest filing 2021-03-09 Proxy Solicitation & In…
Country KR South Korea
Listing KO 054180

About MEDICOX Co., Ltd.

https://www.medicox.co.kr

MEDICOX Co., Ltd., formerly ChoongAng Ocean Co Ltd, is a company engaged in the manufacture and sale of shipbuilding materials and equipment. Its primary products are structural components for large vessels, including curved blocks, bow and stern sections, propeller bosses, and engine room parts. In addition to its core shipbuilding business, the company is diversifying into the biopharmaceutical sector, focusing on new drug development and the commercialization of pharmaceutical products.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit proxies from shareholders for an upcoming General Meeting of Shareholders. It contains details about the meeting agenda, such as amendments to the articles of incorporation, director/auditor compensation limits, and other proposals. This falls under the category of Proxy Solicitation & Information Statement.
2021-03-09 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by the company Meditox. It contains key financial data, audit opinions (적정), and financial statements for the fiscal year. In the context of Korean regulatory filings (DART), this specific format is the standard disclosure for the submission of the annual audit report, which serves as the primary financial disclosure for the period. It is not merely an announcement of a report, but the actual disclosure of the audited financial results and audit opinion. FY 2020
2021-03-08 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a 'Resolution for Convening a General Meeting of Shareholders' (주주총회소집결의) and a subsequent correction (정정신고) regarding the agenda items for the upcoming Annual General Meeting. It details the date, location, and specific agenda items (such as board remuneration and articles of incorporation changes) to be voted on or reported at the meeting. This falls under the category of materials provided to shareholders to inform them of meeting details and agenda, which is classified as Proxy Solicitation & Information Statement.
2021-03-08 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Medicox. It outlines the date, location, and agenda items (such as financial statement approval, board remuneration, and articles of incorporation changes) for the upcoming Annual General Meeting. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and the matters to be voted upon, which fits the definition of Proxy Solicitation & Information Statement (PSI).
2021-03-03 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from a South Korean company (Medicox) regarding a 'Capital Increase Decision' (유상증자결정). It details the correction of previously filed information (정정신고), including changes to subscription dates, payment dates, and listing dates for new shares. This is a formal regulatory filing concerning capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2021-02-23 Korean
[기재정정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a 'Securities Registration Statement' (증권신고서) filed in South Korea, specifically detailing a capital increase (rights offering) and subsequent amendments (정정신고). It contains detailed information about the offering process, subscription dates, share allocation, and risk factors. This type of filing is a regulatory document related to capital structure changes and share issuance. Given the specific options provided, 'SHA' (Share Issue/Capital Change) is the most accurate classification for a document detailing a rights offering and its associated amendments.
2021-02-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.